SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Income Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Expenditure | ₹395 Cr | ₹478 Cr | ₹453 Cr | ₹453 Cr |
What is the latest Total Expenditure of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹395 Cr |
| Mar2025 | ₹478 Cr |
| Mar2024 | ₹453 Cr |
| Mar2023 | ₹453 Cr |
How is Total Expenditure of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹395 Cr | -17.32 | |
| Mar2025 | ₹478 Cr | 5.48 | |
| Mar2024 | ₹453 Cr | 0.00 | |
| Mar2023 | ₹453 Cr | - | |
Compare Total Expenditure of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,789.1 Cr | -3.8% | -13.3% | 32.3% | Stock Analytics | |
| PRIME FOCUS | ₹21,365.7 Cr | -4.8% | -18.4% | 62.3% | Stock Analytics | |
| SAGILITY | ₹20,831.9 Cr | 1.1% | -3.2% | -2.3% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹16,648.9 Cr | 19.8% | 16% | 13.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹14,522.0 Cr | -9.5% | -5.7% | -42.5% | Stock Analytics | |
| INDEGENE | ₹14,489.1 Cr | 2.4% | 0.5% | 5.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -3.8% |
-13.3% |
32.3% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses